Read more about the article Beroni Pharmaceutical (Guangdong) Co., Ltd. Won the 3rd Prize of the Enterprise Group of Jingniuhui “Biomedical and Medical Devices” with the Innovative Drug for Advanced Solid Tumor Project
The award site of Beroni Pharmaceutical (Guangdong) Co., Ltd.

Beroni Pharmaceutical (Guangdong) Co., Ltd. Won the 3rd Prize of the Enterprise Group of Jingniuhui “Biomedical and Medical Devices” with the Innovative Drug for Advanced Solid Tumor Project

  • Post author:
  • Post category:2022
  • Post comments:0 Comments

The award site of Beroni Pharmaceutical (Guangdong) Co., Ltd. On December 19, 2022, the finals of the 8th “Jingniuhui” Venture Competition of Zhuhai Hi-tech Zone was launched in Zhuhai Hi-tech…

Continue ReadingBeroni Pharmaceutical (Guangdong) Co., Ltd. Won the 3rd Prize of the Enterprise Group of Jingniuhui “Biomedical and Medical Devices” with the Innovative Drug for Advanced Solid Tumor Project
Read more about the article Beroni Group Attending the Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association
Group photo

Beroni Group Attending the Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association

  • Post author:
  • Post category:2022
  • Post comments:0 Comments

On November 5, 2022, Beroni Group was invited to participate in the  “Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association”, which was sponsored…

Continue ReadingBeroni Group Attending the Third TMU Pharmaceutical Forum and Annual Meeting of Pharmaceutical Branch of China National Health Association
Read more about the article Successful Conclusion to the First “Industry, University Research and Application, Innovative Medicine” Summit Forum and the Establishment of Tianjin Biomedical Discipline Innovation Consortium
Group photo of the preparatory meeting

Successful Conclusion to the First “Industry, University Research and Application, Innovative Medicine” Summit Forum and the Establishment of Tianjin Biomedical Discipline Innovation Consortium

  • Post author:
  • Post category:2022
  • Post comments:0 Comments

On August 28, 2022, the first “Industry, University Research and Application, Innovative Medicine” Summit Forum ((hereinafter referred to as the “Forum”)) and the inaugural meeting of Tianjin Biomedical Discipline Innovation…

Continue ReadingSuccessful Conclusion to the First “Industry, University Research and Application, Innovative Medicine” Summit Forum and the Establishment of Tianjin Biomedical Discipline Innovation Consortium
Read more about the article Beroni Announces Beilemei’s Brand Endorser—Dan Zhu, World Champion in Rhythmic Gymnastics
Beroni Announces Beilemei’s Brand Endorser—Dan Zhu, World Champion in Rhythmic Gymnastics

Beroni Announces Beilemei’s Brand Endorser—Dan Zhu, World Champion in Rhythmic Gymnastics

  • Post author:
  • Post category:2022
  • Post comments:0 Comments

Beroni Announces Beilemei’s Brand Endorser—Dan Zhu, World Champion in Rhythmic Gymnastics On July 10, 2022, Beroni Group signed agreement with Dan Zhu, world champion in rhythmic gymnastics to invite her…

Continue ReadingBeroni Announces Beilemei’s Brand Endorser—Dan Zhu, World Champion in Rhythmic Gymnastics

Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits from Japan

  • Post author:
  • Post category:2021
  • Post comments:0 Comments

NEW YORK and SYDNEY, Australia, November 18, 2021 (GLOBE NEWSWIRE) - Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research,…

Continue ReadingBeroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits from Japan

Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal

  • Post author:
  • Post category:2021
  • Post comments:0 Comments

NEW YORK and SYDNEY, Australia, October 28, 2021 (GLOBE NEWSWIRE) - Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based biopharmaceutical enterprise, today announced that its article…

Continue ReadingBeroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal